Earnings Call · Q3 FY2022·2022-10-26

Q3 22EPS -12.36%·Rev n/aQ2 22EPS -4.76%·Rev n/aQ1 22EPS +0.88%·Rev n/aQ4 21EPS -19.53%·Rev n/a⚠ consensus missing

USANA HEALTH SCIENCES INC USNA

Andrew Masuda — Investor Relations

Kevin Guest — Executive (likely CEO or similar senior management)

−2.4%1d on move date−1.6% vs SPY3d−5.1%5d−7.7%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more USNA calls or request research access.

More USNA calls Browse calls Request research access